Bakuchiol Induces Apoptosis in Human Hepatocellular Carcinoma Cells HepG2 Via Enhancing Bcl-2/Bax/Cyc-t/Caspase-3 Signaling Pathway

Xiangzi Zhang,Zihan Zhao,Feixue Wang,Zhengai Chen
DOI: https://doi.org/10.3923/ijp.2024.862.873
2024-01-01
International Journal of Pharmacology
Abstract:Background and Objective: While certain natural plant products exhibit clear anti-cancer properties, the inhibitory effect of bakuchiol (BAK), a natural phenolic compound from the Leguminosae family of Rosaceae, on hepatic cancer and its mechanism remains unreported. This study aimed to explore the inhibitory effect of BAK on Hepatocellular Carcinoma Cells (HepG-2 cells) and to preliminarily investigate its potential mechanism. Materials and Methods: In brief, HepG-2 cells were exposed to BAK at concentrations ranging from 0 to 20 mu M for 48 hrs. The MTT assay was used to assess the cell inhibition, HE and Hoechst 33342 staining were used to identify the morphological changes of cells and nuclei, apoptosis and cell cycle arrest were detected using apoptosis kit, cell cycle kit and flow cytometry and western blotting was employed to analyzed the expression of key proteins in the apoptotic pathway Bcl-2/Bax/Cyt-c/Caspase-3. Results: The BAK significantly inhibited the proliferation of HepG-2 cells. The BAK treatment induced pronounced cellular morphological abnormalities, with enlarged cell gaps, wrinkled cell membranes, shrunken nuclei with deep staining-typical apoptotic features. The BAKtreated group showed marked S-phase arrest, with a significant decrease in the proportion of cells in the G0/G1 phase (p<0.01). These changes pronounced with increasing BAK concentration. In the BAK groups, the expression of pro-apoptotic proteins Bax, Cyt-c, Caspase-3, Caspase-9 and p53 was significantly up-regulated and the expression of apoptosis inhibiting protein Bcl-2 was significantly down-regulated. Conclusion: The BAK effectively suppressed HepG-2 cells proliferation, likely by inducing apoptosis through enhancing the apoptotic pathway Bcl-2/Bax/Cyt-c/Caspase-3 and by causing S-phase arrest. This study provides an initial insight into the anti-hepatic cancer activity and potential mechanism of BAK, serving as a foundational basis for further in-depth exploration of BAK's anti-cancer mechanisms and its potential clinical applications.
What problem does this paper attempt to address?